Intracranial Aneurysm Market Size, Share, Industry Trends and Forecast to 2030

Intracranial Aneurysm Market Size & CAGR in 2021

The global intracranial aneurysm market is projected to have a growth rate of 4.5% CAGR from 2021 to 2025. The market size is expected to reach USD 2.4 billion by the end of 2025. The increasing prevalence of intracranial aneurysms, technological advancements in treatment procedures, and growing awareness among patients are some of the key factors driving market growth.

COVID-19 Impact on the Intracranial Aneurysm Market

The COVID-19 pandemic has had a significant impact on the intracranial aneurysm market. The global healthcare infrastructure faced challenges due to the overwhelming number of COVID-19 cases, leading to delays in elective surgeries for intracranial aneurysms. However, with the rollout of vaccination campaigns and improved healthcare protocols, the market is expected to recover steadily over the forecast period.

Intracranial Aneurysm Dynamics

The dynamics of the intracranial aneurysm market are influenced by factors such as the increasing geriatric population, rising healthcare expenditure, advancements in imaging technologies for accurate diagnosis, and the growing demand for minimally invasive procedures. Additionally, the prevalence of risk factors such as hypertension, smoking, and family history contributes to the growth of the market.

Segments and Related Analysis

The intracranial aneurysm market is segmented based on type, treatment, end-user, and region. By type, the market is divided into saccular aneurysms, fusiform aneurysms, and others. Treatment options include surgical clipping, endovascular coiling, and flow diversion. Hospitals, clinics, and ambulatory surgical centers are the main end-users of intracranial aneurysm treatments. Regional analysis provides insights into market trends in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

By Region Analysis

North America dominates the global intracranial aneurysm market, owing to the presence of advanced healthcare infrastructure, high prevalence of risk factors, and favorable reimbursement policies. Europe and Asia Pacific follow closely behind, with increasing awareness about the condition and rising investments in healthcare. Latin America and the Middle East & Africa regions show potential for significant market growth due to improving healthcare facilities and rising healthcare expenditure.

Key Market Players and Competitive Landscape

Some of the key players in the intracranial aneurysm market include Stryker Corporation, Medtronic, MicroPort Scientific Corporation, Terumo Corporation, Johnson & Johnson Services, Inc., and Penumbra, Inc. These companies focus on research and development activities, collaborations, and product innovations to maintain their competitive edge in the market. The competitive landscape is characterized by mergers, acquisitions, and strategic partnerships among key players.

Recent Happenings in the Intracranial Aneurysm Market

In recent developments, Stryker Corporation introduced a new minimally invasive device for the treatment of intracranial aneurysms, aiming to provide safer and more effective treatment options for patients. Medtronic announced the expansion of its portfolio of endovascular devices for the management of complex intracranial aneurysms, further enhancing its market presence. These advancements signify the ongoing efforts by market players to address the evolving needs of patients with intracranial aneurysms.